<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report Pursuant
to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
January 11, 2001
----------------------
AMERICAN BIOGENETIC SCIENCES, INC.
--------------------------------------------------------------------------------
(Exact Name Of Registrant As Specified In Its Charter)
Delaware
--------------------------------------------------------------------------------
(State or Other Jurisdiction of Incorporation)
0-19041 11-2655906
--------------------------------------------------------------------------------
(Commission File Number) (I.R.S. Employer Identification No.)
1375 Akron Street, Copiague, New York 11726
--------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
(631) 789-2600
--------------------------------------------------------------------------------
(Registrant's Telephone Number, Including Area Code)
<PAGE> 2
ITEM 5. OTHER EVENTS.
The Registrant has made certain changes in management, as described in
its press release dated January 11, 2001, which is filed as an exhibit to this
form.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
99.1 Press release dated January 11, 2001.
2
<PAGE> 3
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this Report to be signed on its behalf by the
undersigned, thereunto duly authorized.
AMERICAN BIOGENETIC SCIENCES, INC.
Dated: January 11, 2001
By: /s/ Josef C. Schoell
--------------------------------------
Josef C. Schoell
President, Chief Operating Officer and
Chief Financial Officer
3
